Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
05/2012
05/03/2012US20120107321 Antibodies And Epitopes Specific To Misfolded Prion Protein
05/03/2012US20120107319 Pharmaceutical compositions comprising antibodies binding to the intracellular domain of EBV (Epstein-Barr virus) latent membrane protein-1 (LMP1)
05/03/2012US20120107318 Methods of administering pif agonist peptides and uses thereof
05/03/2012US20120107243 Peptide-mediated non-covalent delivery of active agents across the blood-brain barrier
05/03/2012US20120107237 Arg-gly-asp-conjugated alpha-melanocyte stimulating hormone hybrid peptide for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same
05/03/2012CA2815270A1 Process for the manufacture of degarelix and its intermediates
05/02/2012EP2447718A1 Novel capture agent for binding a ligand
05/02/2012EP2447276A1 Process for the manufacture of Degarelix and its intermediates
05/02/2012EP2446862A2 Amphiphilic peptides and hydrogel matrices thereof for bone repair
05/02/2012EP2445932A1 Soricidin derived peptides and methods for the detection of trpv-6 cancers and drug delivery
05/02/2012EP2445926A1 Biologically produced cyclic affinity tags
05/02/2012EP1678200B1 A method of modulating cell survival, differentiation and/or synaptic plasticity
05/02/2012CN102439451A Identification of small molecules recognized by antibodies in subjects with neurodegenerative diseases
05/02/2012CN102439147A Vangl1 peptides and vaccines including the same
05/02/2012CN102439137A Method for preparing dendritic cells with capacity to induce cancer-specific immune response, and pharmaceutical composition and kit incorporating dendritic cells for preventing or treating cancer or inhibiting metastasis
05/02/2012CN102439027A Peptide hydrolysate proteasome activators and compositions containing same
05/02/2012CN102438643A Compositions and methods for treatment of celiac disease
05/02/2012CN102432674A Method for purifying cyclic lipopeptide compound or salt thereof
05/02/2012CN102432673A Brucella bp26 protein epitope, monoclonal antibody and application thereof
05/02/2012CN102432672A Novel synthesis antibacterial peptides and application thereof
05/02/2012CN102432671A Targeting polypeptide SPSCVLP capable of inhibiting growth and transfer of liver cancer and application thereof
05/02/2012CN101805392B Anti-inflammatory antibacterial polypeptide capable of blocking combination of LPS and MD2
05/02/2012CN101671386B Lepista sordida protein LsAPI, preparation method and application thereof
05/02/2012CN101560245B CTL epitope polypeptide of avian influenza H5N1 virus and application thereof
05/02/2012CN101519437B Cyclic heptapeptide compound in Hsisha sponge and application thereof
05/01/2012US8168748 Peptide aptamers that bind to the rep proteins of ssDNA viruses
05/01/2012US8168747 On-growth inhibiting compounds
05/01/2012US8168585 Purification of peptides from colostrum
05/01/2012US8168191 Cytotoxic T lymphocyte
05/01/2012CA2379858C Beta-amyloid peptide inhibitors
04/2012
04/26/2012WO2012054565A1 Methods and compositions for modulating the wnt pathway
04/26/2012WO2012054500A2 Compositions for drug administration
04/26/2012WO2012053206A1 Wdhd1 peptides and vaccines including the same
04/26/2012WO2012053200A1 C18orf54 peptides and vaccines including the same
04/26/2012WO2012051663A1 Antimicrobial compounds
04/26/2012WO2012002668A3 Novel peptide and use thereof
04/26/2012WO2011163398A3 Biomimetic peptides for bone augmentation
04/26/2012WO2011149909A3 Class i mhc phosphopeptides for cancer immunotherapy and diagnosis
04/26/2012WO2011147797A3 Hybrid compound, the use thereof, and method for the production thereof
04/26/2012WO2011119008A3 Peptides for promoting angiogenesis and an use thereof
04/26/2012US20120101253 Structured polycyclic peptide
04/26/2012US20120101048 Compounds for enzyme inhibition
04/26/2012US20120101044 Gold (iii) complexes with oligopeptides functionalized with sulfur donors and use thereof as antitumor agents
04/26/2012US20120101028 Anti-inflammatory compounds and uses thereof
04/26/2012US20120101022 Self-assembling peptides bearing organic electronic functionality and applications employing the same
04/26/2012US20120100562 Methods and compositions for modulating the wnt pathway
04/26/2012US20120100172 Immunogenic streptococcus pneumoniae peptides and peptide-multimers
04/26/2012US20120100166 Ang-2 Binding Complexes and Uses Thereof
04/26/2012CA2815102A1 Wdhd1 peptides and vaccines including the same
04/26/2012CA2815100A1 C18orf54 peptides and vaccines including the same
04/26/2012CA2814927A1 Compositions for drug administration
04/26/2012CA2812785A1 Methods and compositions for modulating the wnt pathway
04/25/2012EP2444414A1 Peptidic antigen that induces antibody recognizing three-dimensional structure of hiv and method for synthesizing same
04/25/2012EP2444412A2 Peptide production and purification process
04/25/2012EP2444100A2 Vaccine comprising Amb a 1 peptides for use in the treatment of ragweed allergy
04/25/2012EP2443143A1 Casein derived protease inhibitory peptides
04/25/2012EP2443137A1 Novel chemokine binding polypeptides capable of inhibiting the course of autoimmunity, inflammation and cancer
04/25/2012EP2265631B1 Novel antimicrobial peptides and their application
04/25/2012CN102428098A Novel solid materials of {[2s, 5r,8s,11s)-5-benzyl-11-(3-guanidino-propyl)-8-isopropyl-7-methyl-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid} and methods for obtaining them
04/25/2012CN102428097A 地加瑞克的制造方法 The method of manufacturing of degarelix
04/25/2012CN102428096A Cell membrane-permeable peptides
04/25/2012CN102428095A 新型蛋白酶体激活性抗衰老肽及含有所述肽的组合物 Novel protease-activating anti-aging peptides and compositions containing the peptides
04/25/2012CN101974076B 抑制由碱性成纤维细胞生长因子诱导的细胞增殖及血管增生的环肽 Inhibition by basic fibroblast growth factor-induced cell proliferation and angiogenesis cyclic peptide
04/25/2012CN101607984B 一种多拷贝多肽及其应用 A multi-copy peptide and its application
04/25/2012CN101597325B 一种纯化亮丙瑞林(Leuprorelin)的方法 A leuprolide (Leuprorelin) of purified
04/25/2012CN101434649B 一种环七肽及其制备方法和应用 A cyclic heptapeptide and its preparation method and application
04/25/2012CN101372506B 一种纯化制备爱啡肽的新工艺 A new process of love FQ purified by preparative
04/25/2012CN101314613B 一种阿托西班的固相合成方法 Solid-phase synthesis method atosiban
04/24/2012US8163890 Production of recombinant proteins by autoproteolytic cleavage of a fusion protein
04/24/2012US8163876 DNA sequences, vectors and proteins of avian influenza hemagglutinin
04/24/2012US8163871 Enzymatic reactions in the presence of keto acids
04/24/2012US8163701 Prodrugs of active agents
04/24/2012US8163698 Dolastatin 15 derivatives
04/24/2012CA2614171C Copolymers for suppression of autoimmune diseases, and methods of use
04/24/2012CA2499496C Synthesis and characterization of novel systems for guidance and vectorization of compounds having a therapeutic activity
04/24/2012CA2485959C Polypeptide cleavage process
04/24/2012CA2425599C Fumaric acid amides
04/24/2012CA2414609C Synthetic methods for aplidine and new antitumoral derivatives, methods of making and using them
04/24/2012CA2339529C Isolated and purified human soluble guanylyl cyclase .alpha.1/.beta.1 (hsgc .alpha.1/.beta.1)
04/19/2012WO2012051207A2 FRAGMENT OF SECRETED HEAT SHOCK PROTEIN-90ALPHA (Hsup90ALPHA) AS VACCINES OR EPITOPE FOR MONOCLONAL ANTIBODY DRUGS OR TARGET FOR SMALL MOLECULE DRUGS AGAINST A RANGE OF SOLID HUMAN TUMORS
04/19/2012WO2012051194A1 Cyclosporin analogs
04/19/2012WO2012051193A1 Cyclosporin analogs
04/19/2012WO2012050193A1 Ebola virus liposome vaccine
04/19/2012WO2012048755A1 Er-alpha-17p peptide, effects on stem cell differentiation
04/19/2012WO2012048553A1 Escherichia coli tolc antigen, antibody and use thereof
04/19/2012WO2011153512A3 Use of compounds with thrombopoietic activity to promote bone growth and healing
04/19/2012WO2011149310A3 Peptide for inhibiting interaction between rankl and rank, and pharmaceutical composition containing same
04/19/2012WO2011123826A3 Prevention and treatment of cast nephropathy
04/19/2012US20120094938 Small Peptides And Methods For Treatment Of Chronic Inflammatory Bowel Disease
04/19/2012US20120094924 Nucleic acid delivery compounds
04/19/2012US20120094921 Cosmetic and/or pharmaceutical composition comprising a relieving peptidic hydrolyzate
04/19/2012US20120094920 Cosmetic and/or pharmaceutical composition comprising a peptidic hydrolyzate that can reinforce the barrier function
04/19/2012US20120094917 Iap inhibitors
04/19/2012US20120094911 Endokinin c/d-derived peptides
04/19/2012US20120094910 Improved process for the preparation of desmopressin or its pharmaceutically acceptable salts
04/19/2012US20120094899 Neuromedin u derivative
04/19/2012US20120094898 Peptide derivative
04/19/2012US20120094896 Inhibitors of viral integrase and methods of use
04/19/2012US20120094892 Prodrugs
04/19/2012US20120094864 Extracellular allosteric inhibitor binding domain from a tyrosine kinase receptor
1 ... 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 ... 423